Dr. David Spencer Rogawski, MD

Dr. Rogawski practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Rogawski's NPI, 1336645514, was assigned on April 5, 2018. Dr. Rogawski graduated from University Of Michigan Medical School in 2015. Dr. Rogawski holds California license A166836.

Dr. Rogawski's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Rogawski's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Rogawski to 1 more hospital and 1 medical group, each named with a free account. Dr. Rogawski's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rogawski practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rogawski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rogawski is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Rogawski is licensed in California.

CMS data shows 26 Medicare services from Dr. Rogawski across 2 procedure codes in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $3,617 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Rogawski in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rogawski's median patient age at 55, with 60% women.

In 2021, Dr. Rogawski wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $844 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Rogawski for performance year 2024, reported as part of a group. Dr. Rogawski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rogawski as offering telehealth.

Dmand AI links 10 papers to Dr. Rogawski, published from 2015 to 2024. 2016 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Enzyme Inhibitors and Histone-Lysine N-Methyltransferase. Dr. Rogawski has published most often in Nat Commun. Dr. Rogawski's most frequent co-authors are Juliano Ndoj, DO, Oren Josh Becher, MD and Toni Qian Cao, MD.

Dr. Rogawski graduated from University Of Michigan Medical School in 2015.

Dr. Rogawski is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.